Quick Answer
Satellos Bioscience Inc. reported r&d expense of $18.43 million for fiscal year 2025 (IFRS, Form 20-F).
Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted.
Satellos Bioscience Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $18.43M | +28.3% |
| 2024 | $14.36M | — |
- Satellos Bioscience Inc.’s r&d expense rose 28.3% year over year.
- The most recent figure is from Satellos Bioscience Inc.’s fiscal year 2025 annual report (Form 20-F), filed March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 19, 2026.
Last verified: